De-novo expression of CD44 and survival in gastric cancer.
about
Clinicopathological and prognostic significance of cancer stem cell markers CD44 and CD133 in patients with gastric cancer: A comprehensive meta-analysis with 4729 patients involved.Expression of CD44 and its variant isoform v3 has no prognostic value in gastric cancer.Effectiveness of plasma treatment on gastric cancer cells.A CD44-specific peptide, RP-1, exhibits capacities of assisting diagnosis and predicting prognosis of gastric cancer.Molecular biology of gastric carcinoma: from laboratory to bedside.CD44v6 in peripheral blood and bone marrow of patients with gastric cancer as micro-metastasis.Loss of CPSF2 expression is associated with increased thyroid cancer cellular invasion and cancer stem cell population, and more aggressive disease.Prognostic significance of CD44s expression in resected non-small cell lung cancer.Expression of mutant p53 protein and CD44 variant proteins in colorectal tumorigenesisExpression of CD44 and its variants on gastric epithelial cells of patients with Helicobacter pylori colonisation.Effects of body-resistance strengthening and tumor-suppressing granules on immune adhesion function of red blood cells and expression of metastasis protein CD44 in tumor cells of patients with esophageal carcinoma.Role of cancer stem cell marker CD44 in gastric cancer: a meta-analysisExpression of CD44 variants and prognosis in oesophageal squamous cell carcinoma.CD44 family proteins in gastric cancer: a meta-analysis and narrative reviewScreening and Identification of a Phage Display Derived Peptide That Specifically Binds to the CD44 Protein Region Encoded by Variable Exons.Gastric cancer stem cells: evidence, potential markers, and clinical implications.Reduced level of CD44 and hyaluronan associated with unfavorable prognosis in clinical stage I cutaneous melanoma.Expression of CD44 in human neoplastic and normal hyaline cartilage.Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer.Identification and expansion of cancer stem cells in tumor tissues and peripheral blood derived from gastric adenocarcinoma patientsImmunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer.Differential CD44 expression patterns in primary brain tumours and brain metastases.Cytokeratin 20 mRNA in peripheral venous blood of colorectal carcinoma patientsHigh serum levels of soluble CD44 variant isoform v5 are associated with favourable clinical outcome in ovarian cancer.Loss of Ep-CAM (CO17-1A) expression predicts survival in patients with gastric cancer.Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate.Expression of CD44 by rhabdomyosarcoma: a new prognostic marker?The hyaluronic acid receptor CD44 coordinates normal and metaplastic gastric epithelial progenitor cell proliferationDifferential expression of CD44v6 in metastases of intestinal and diffuse types of gastric carcinomaExpression of CD44H and CD44v3 in normal oesophagus, Barrett mucosa and oesophageal carcinoma.Akt-p53-miR-365-cyclin D1/cdc25A axis contributes to gastric tumorigenesis induced by PTEN deficiencyThe combined expression of metaplasia biomarkers predicts the prognosis of gastric cancerIdentification of differently expressed genes with specific SNP Loci for breast cancer by the integration of SNP and gene expression profiling analyses.Winding back Wnt signalling: potential therapeutic targets for treating gastric cancers.Visualization of CD44 and CD133 in normal pancreas and pancreatic ductal adenocarcinomas: non-overlapping membrane expression in cell populations positive for both markers.Cross-linked hyaluronic acid sub-micron particles: in vitro and in vivo biodistribution study in cancer xenograft model.Cotransfection of survivin and CD44v3 short hairpin RNAs affects proliferation, apoptosis, and invasiveness of colorectal cancer.Therapeutic potential of hyaluronan oligosaccharides for bone metastasis of breast cancer.Abnormal expression of the human CD44 gene in early colorectal malignancy with special reference to variant exon 9 (9v).De novo expression of CD44 in prostate carcinoma is correlated with systemic dissemination of prostate cancer.
P2860
Q30244324-EAD09914-106F-4A05-8E0C-FF123F53E140Q31789296-7D579841-4EEA-4CDC-B4E6-5DD05CCB0B12Q33462141-094C3BE8-5874-4A03-BBCE-7472461AADFEQ33728237-19E9935D-2DA7-44E6-91DE-5B7E6D74BD02Q33816796-E17E05FC-8784-4A05-9C0D-04E934CB48A7Q33829845-C34CA2BF-1B3E-4C3F-A47B-ED0BD2AC69FCQ33837093-8D807E1A-339B-467D-8E62-02A3D5A42768Q33984061-96077938-31DD-4386-BACB-DEB919E9C4C5Q34407461-87C44E42-36D1-4EA1-B206-7D00D5C0A011Q34409537-FC75D1D1-D41D-4292-8AA5-5D07A9E414A4Q34606102-ADC6493C-337F-4F28-8274-F49CD32306D7Q35017054-05D541E3-936C-4EE3-A515-1D3C525C87FFQ35358588-94C16715-5A76-40DB-A7E2-954AFE295444Q35643626-B2228072-ACE7-4143-A78C-641BF1843C4DQ35794084-4D47DA6E-E754-4FBA-8334-3223E8F326FCQ35795934-5B2F411E-6EC3-4649-A1B4-3B2EF7C139A9Q35829460-A80EC063-986A-4501-B293-ED0C99C79A4FQ35836306-75327B5A-EBE9-49CE-9A2D-9380B3B2AD2FQ35837359-11FFBADE-2059-48EA-8D8E-618941F00042Q35958829-51472700-7F2E-4554-8D63-655D7911479EQ36081751-AA3EBB85-542B-460B-8129-973D3AA70549Q36081878-1433A0C8-DF91-4581-AC6F-461F0A2192F5Q36292406-7AF540DF-7F16-4CC7-AF3B-693FF28BB7B6Q36431610-DB11D00B-ACFD-4F37-BF89-6261404187EEQ36616818-C858210F-DA3C-4A2B-9DCD-8465CB855DABQ36617504-6D902CE4-DDF9-4AFB-9C88-EBA1E173584AQ36617661-287F2E50-06DC-4892-82B1-83EF61D2CE87Q36890737-52373D0E-41E2-461D-8B31-6C81AC3A2D25Q37217754-39F6189F-B346-41C6-8C2A-80FDC1BB53F0Q37218372-5FAE9750-ADC5-4C8B-880E-5A7C4ED03F43Q37305250-48C8097A-7427-4051-A171-83952ECD08C0Q37448891-F6048675-1845-4BC3-9EC6-B96767235D59Q38470379-92907B0B-03FC-4F6B-A112-1DC2AD6D863FQ38751688-F78AD896-66A4-4384-8CBC-30255046D104Q38820117-791D3E3F-2FC8-4E43-A68B-E9E22C919185Q39183455-5C5A59C6-120C-469A-858C-EF56F7917BD5Q39200251-FDB8B737-8F64-4925-99F0-E80D3068D16DQ39474674-242A59D1-2611-4DD2-AA5E-C73E3EDADA14Q39589169-B2B72F0D-7A42-48AE-9416-19CB1590AA7DQ39604319-78736A74-8ED1-4E2D-AA2D-BC16D57E73CE
P2860
De-novo expression of CD44 and survival in gastric cancer.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
De-novo expression of CD44 and survival in gastric cancer.
@en
De-novo expression of CD44 and survival in gastric cancer.
@nl
type
label
De-novo expression of CD44 and survival in gastric cancer.
@en
De-novo expression of CD44 and survival in gastric cancer.
@nl
prefLabel
De-novo expression of CD44 and survival in gastric cancer.
@en
De-novo expression of CD44 and survival in gastric cancer.
@nl
P2093
P1433
P1476
De-novo expression of CD44 and survival in gastric cancer.
@en
P2093
P304
P356
10.1016/0140-6736(93)92879-X
P407
P50
P577
1993-10-01T00:00:00Z